A New Frontier in Diabetes Care: Breakthrough Phase 2b Results for Oral GLP-1 Candidate Elecoglipron
Comments Off on A New Frontier in Diabetes Care: Breakthrough Phase 2b Results for Oral GLP-1 Candidate Elecoglipron
June 16, 2026
The landscape of type 2 diabetes management is poised for a significant transformation as researchers unveil promising data regarding the next generation of oral GLP-1 receptor agonists. At the American Diabetes Association’s (ADA) recent Scientific…